2004
DOI: 10.1529/biophysj.104.046664
|View full text |Cite
|
Sign up to set email alerts
|

The External TEA Binding Site and C-Type Inactivation in Voltage-Gated Potassium Channels

Abstract: The location of the tetraethylammonium (TEA) binding site in the outer vestibule of K+ channels, and the mechanism by which external TEA slows C-type inactivation, have been considered well-understood. The prevailing model has been that TEA is coordinated by four amino acid side chains at the position equivalent to Shaker T449, and that TEA prevents a constriction that underlies inactivation via a foot-in-the-door mechanism at this same position. However, a growing body of evidence has suggested that this pict… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
25
0

Year Published

2005
2005
2015
2015

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 36 publications
(27 citation statements)
references
References 41 publications
2
25
0
Order By: Relevance
“…Among tested ligands, only 4AP did not compete with R-AgTx2 for binding to the pore region of KcsA-Kv1.1, because 4AP binds to the site located on the inner side of the channel pore (44,45). Another small organic molecule TEA can bind to potassium channels on either side (43). These results provide confirmatory evidence that the hybrid KcsA-Kv1.1 channel possesses, in general, a Kv1.1 ligand affinity profile, and that the novel test system based on KcsA-Kv1.1-expressing spheroplasts can be used for toxin screening.…”
Section: Discussionsupporting
confidence: 64%
“…Among tested ligands, only 4AP did not compete with R-AgTx2 for binding to the pore region of KcsA-Kv1.1, because 4AP binds to the site located on the inner side of the channel pore (44,45). Another small organic molecule TEA can bind to potassium channels on either side (43). These results provide confirmatory evidence that the hybrid KcsA-Kv1.1 channel possesses, in general, a Kv1.1 ligand affinity profile, and that the novel test system based on KcsA-Kv1.1-expressing spheroplasts can be used for toxin screening.…”
Section: Discussionsupporting
confidence: 64%
“…Indeed, a similar interaction with a bacterial channel has been modeled with molecular dynamics (Crouzy et al, 2001;Guidoni and Carloni, 2002;Luzhkov et al, 2003) and studied by crystallization with TEA analogs (Lenaeus et al, 2005). However, site-directed mutagenesis and chemical modification results have called this model into question for Kv2.1: although the tyrosine side chain clearly has a role in external TEA block, it may not cage or bind TEA stably or directly in mammalian Kv2.1 channels (Pascual et al, 1995;Andalib et al, 2004). The uncertainty in the mechanism of the TEA block of Kv2.1 makes interpretation of the competition between TEA and 48F10, but not catechol and many derivatives, difficult to interpret in structural terms.…”
Section: Discussionmentioning
confidence: 99%
“…According to some reports, Kv2.1 residue Tyr380 (equivalent to KcsA Tyr82 and Shaker Thr449) in the outer pore (Fig. 9C) forms at least part of the external TEA binding site (MacKinnon and Yellen, 1990;Heginbotham and MacKinnon, 1992;Luzhkov and Aqvist, 2001) although this has been subsequently disputed (Pascual et al, 1995;Crouzy et al, 2001;Andalib et al, 2004). The finding that Kv channels with an aromatic residue in this position are highly sensitive to block by external TEA was suggested to explain the higher TEA affinity of wild-type Kv2.1 compared with wild-type Shaker (MacKinnon and Yellen, 1990).…”
Section: Resultsmentioning
confidence: 99%
“…Methanethiosulfonate forms the basis for a group of compounds that are able to bind irreversibly to the free sulfhydryl group of cysteine residues that line the pore of channels (Akabas et al, 1992;Karlin and Akabas, 1998). As was demonstrated by the Korn group (Andalib et al, 2004), introduction of a cysteine at position 356 in Kv2.1 made this position modifiable with MTSET, resulting in permanent fractional block. However, when TEA was administered before MTSET, this ability to permanently modify the introduced cysteine was lost.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation